AstraZeneca pledges fifteen billion dollars to expand operations in China through twenty thirty
AstraZeneca announced a fifteen billion dollar investment in China to expand research and manufacturing. The deal aims to boost medical innovation through 2030.
Insights:
AstraZeneca PLC announced on January 29, 2026, that it will invest $15 billion in China 
CNthrough 2030 to expand its medicines manufacturing and research and development operations. The announcement was made during a high-profile visit by British Prime Minister Keir Starmer keir starmerto Beijing, marking the largest deal signed during the trip. This commitment represents the company’s largest investment in the country to date, as the pharmaceutical giant seeks to strengthen its presence in its second-biggest market.
CNthrough 2030 to expand its medicines manufacturing and research and development operations. The announcement was made during a high-profile visit by British Prime Minister Keir Starmer keir starmerto Beijing, marking the largest deal signed during the trip. This commitment represents the company’s largest investment in the country to date, as the pharmaceutical giant seeks to strengthen its presence in its second-biggest market.
